Clinical Trial Update: Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of gemcitabine, cisplatin, and ifosfamide in patients with relapsed non-seminomatous germ cell tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Non-seminomatous Germ Cell Tumor
• Testicular Germ Cell Tumor

Drugs mentioned

• Gemzar (gemcitabine)
• Ifex (ifosfamide)
• Platinol (cisplatin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Germ Cell Tumor | Phase 2 | Status: UNKNOWN